A widow is advocating for a change in legislation to eliminate disparities in care for individuals with brain cancer. Ellie James is leading a movement after her husband Owain passed away in 2024 due to a glioblastoma, facing challenges in accessing tailored treatments because most of his tumor, removed during surgery, was not preserved.
Mrs. James is spearheading a campaign to grant patients the option to have their tissue frozen and stored post-surgery, allowing access to personalized therapies and genetic examinations. She highlights the inconsistent application of this practice within the NHS, resulting in uneven care standards based on geographical location.
Advocating for a legal amendment, known as Owain’s Law, she emphasizes the importance of patients being able to provide consent regarding the management of their tissue. Mrs. James firmly believes that her husband might have survived if such legislation had been in effect during his treatment.
The matter will be deliberated in a Westminster Hall debate this week. Mr. James, a father, was diagnosed with brain cancer in September 2022, with surgeons removing half of a 14cm tumor safely during an operation.
Following the surgery, the family fundraised for a personalized treatment for Mr. James. Mrs. James revealed that for the treatment to be effective, fresh frozen tumor tissue was essential, a requirement they were unaware of initially.
Due to only a small portion of the tumor being usable for the vaccine, Mr. James received a limited number of doses compared to what was deemed necessary. Despite a period of positive progress post-vaccination, the tumor eventually returned, leading to his demise in June 2024.
Expressing the need for patient autonomy, Mrs. James asserts that individuals should have the right to decide how their tissue is managed and utilized for future treatments or research. Owain’s Law, according to her, aims to empower patients with choices and informed decisions regarding their medical journey.
